Saturday, November 21, 2026

Minister of Health launches new injectable contraceptive

Minister of Health launches new injectable contraceptive
Lifestyle • Nov 20, 2026

Minister of Health launches new injectable contraceptive

Author

Breaking News Zambia

Lifestyle

Government has launched a new injectable contraceptive, Subcutaneous Medogen, aimed at expanding access to affordable and quality-assured family planning services for women. The product contains 104 milligrams of Medroxyprogesterone Acetate administered through a subcutaneous…

Government has launched a new injectable contraceptive, Subcutaneous Medogen, aimed at expanding access to affordable and quality-assured family planning services for women.

The product contains 104 milligrams of Medroxyprogesterone Acetate administered through a subcutaneous injection and provides protection against pregnancy for three months.

Speaking during the launch, Minister of Health Professor Roma Chilengi, says the introduction of the product will provide women with more contraceptive choices, particularly those who prefer self-injection.

Speaking during the official launch of the product, Professor Chilengi said injectable contraceptives remain the most widely used modern family planning method in Zambia, with 28 percent of women relying on them.

Professor Chilengi cited the 2024 Zambia Demographic and Health Survey, which indicates that modern contraceptive use among currently married women has increased to 53 percent from 48 percent in 2018.

He said the new product, which is a generic and World Health Organisation-prequalified contraceptive, presents an opportunity to provide quality family planning services at potentially lower costs.

Professor Chilengi said the development could also improve the efficiency of Government procurement, strengthen the availability of contraceptive commodities and enable more women to access family planning services.

He emphasised that the Government remains committed to providing a variety of safe, effective and affordable contraceptive methods, noting that women’s reproductive needs and preferences differ.

Professor Chilengi also commended Yash Pharmaceuticals for introducing the product to the Zambian market, saying private-sector investment and innovation are critical to strengthening the country’s healthcare system.

Yash Pharmaceuticals says the introduction of Subcutaneous Medogen into Zambia’s private healthcare sector will expand access to modern contraceptive options and give women greater convenience and autonomy in family planning.

Meanwhile, company’s General Manager, Shankar Shiva, noted that the launch marks an important milestone in the country’s reproductive health sector, as Zambia becomes the first country in the world to introduce the WHO-prequalified DMPA-SC product into the private market.

Incepta Pharmaceuticals Limited, Manager for International Marketing, Ashraful Islam, said the product contains 104 milligrams of Medroxyprogesterone Acetate administered through a subcutaneous injection and provides protection against pregnancy for three months.

Related coverage from breakingnewszambia.com

Community Feedback

No approved comments yet.